$271 Million is the total value of INNOVIS ASSET MANAGEMENT LLC's 162 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DXCM | New | DEXCOM INC | $4,799,206 | – | 37,345 | +100.0% | 1.77% | – |
| ROK | New | ROCKWELL AUTOMATION INC | $4,741,774 | – | 14,393 | +100.0% | 1.75% | – |
| New | BLUE APRON HLDGS INC | $800,799 | – | 137,123 | +100.0% | 0.30% | – | |
| HBI | New | HANESBRANDS INC | $619,039 | – | 136,352 | +100.0% | 0.23% | – |
| TGTX | New | TG THERAPEUTICS INC | $507,780 | – | 20,442 | +100.0% | 0.19% | – |
| TLYS | New | TILLYS INCcl a | $496,154 | – | 70,778 | +100.0% | 0.18% | – |
| RCII | New | UPBOUND GROUP INC | $432,676 | – | 13,899 | +100.0% | 0.16% | – |
| New | DICE THERAPEUTICS INC | $411,218 | – | 8,851 | +100.0% | 0.15% | – | |
| MRUS | New | MERUS N V | $350,163 | – | 13,299 | +100.0% | 0.13% | – |
| VERA | New | VERA THERAPEUTICS INCcl a | $347,852 | – | 21,673 | +100.0% | 0.13% | – |
| PTON | New | PELOTON INTERACTIVE INC | $306,662 | – | 39,878 | +100.0% | 0.11% | – |
| BKI | New | BLACK KNIGHT INC | $299,069 | – | 5,007 | +100.0% | 0.11% | – |
| DNB | New | DUN & BRADSTREET HLDGS INC | $276,477 | – | 23,896 | +100.0% | 0.10% | – |
| AMAM | New | AMBRX BIOPHARMA INCsponsored ads | $276,956 | – | 16,826 | +100.0% | 0.10% | – |
| VZ | New | VERIZON COMMUNICATIONS INC | $269,777 | – | 7,254 | +100.0% | 0.10% | – |
| RVNC | New | REVANCE THERAPEUTICS INC | $266,186 | – | 10,517 | +100.0% | 0.10% | – |
| GTLS | New | CHART INDS INC | $254,866 | – | 1,595 | +100.0% | 0.09% | – |
| PLRX | New | PLIANT THERAPEUTICS INC | $249,368 | – | 13,762 | +100.0% | 0.09% | – |
| CDW | New | CDW CORP | $247,725 | – | 1,350 | +100.0% | 0.09% | – |
| DOMO | New | DOMO INC | $232,992 | – | 15,893 | +100.0% | 0.09% | – |
| SWTX | New | SPRINGWORKS THERAPEUTICS INC | $225,833 | – | 8,613 | +100.0% | 0.08% | – |
| New | PORTILLOS INC | $214,531 | – | 9,522 | +100.0% | 0.08% | – | |
| MGTX | New | MEIRAGTX HLDGS PLC | $204,934 | – | 30,496 | +100.0% | 0.08% | – |
| ETNB | New | 89BIO INC | $197,782 | – | 10,437 | +100.0% | 0.07% | – |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $198,038 | – | 15,328 | +100.0% | 0.07% | – |
| EYPT | New | EYEPOINT PHARMACEUTICALS INC | $165,570 | – | 19,031 | +100.0% | 0.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APPLE INC | 4 | Q3 2023 | 8.1% |
| NVIDIA CORPORATION | 4 | Q3 2023 | 4.0% |
| HESS CORP | 4 | Q3 2023 | 3.7% |
| INTUITIVE SURGICAL INC | 4 | Q3 2023 | 3.1% |
| UNITEDHEALTH GROUP INC | 4 | Q3 2023 | 4.2% |
| CBOE GLOBAL MKTS INC | 4 | Q3 2023 | 3.1% |
| COSTCO WHSL CORP NEW | 4 | Q3 2023 | 2.9% |
| ORACLE CORP | 4 | Q3 2023 | 3.1% |
| MERCK & CO INC | 4 | Q3 2023 | 3.1% |
| VERTEX PHARMACEUTICALS INC | 4 | Q3 2023 | 3.0% |
View INNOVIS ASSET MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-03 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-14 |
View INNOVIS ASSET MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.